Finadyne transdermal 100ml | anti-inflammatory

FINADYNE TRANSDERMAL 

Pour-on Solution for Cattle
Non-steroidal anti-inflammatory with analgesic and antipyretic activity in solution for continuous dorsal anointing
MSD ANIMAL HEALTH Laboratory

Pharmaceutical form
Solution for continuous dorsal anointing (Sol.udc)

Composition per ml:
Active substance: Flunixin 50 mg, equivalent to 83 mg of flunixin meglumine.
Excipients: Levomenthol 50 mg; allura red AC (E 129) 0,2 mg.

Interactions and incompatibilities
• Do not administer other NSAIDs at the same time or within a 24 hour interval.
• Some NSAIDs can be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects. Simultaneous administration of potentially nephrotoxic drugs should be avoided.
• In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.

Indications
Cattle: Reduction of pyrexia associated with bovine respiratory syndrome and acute mastitis; reduction of pain and lameness associated with interdigital phlegmon, interdigital dermatitis and digital dermatitis.
Contraindications
• Do not use in animals with cardiac, hepatic or renal disorders, or with evidence of ulceration or gastrointestinal bleeding.
• Do not use in severely dehydrated, hypovolaemic animals, as there is a potential risk of increased renal toxicity.
• Do not use the veterinary medicinal product within 48 hours prior to the expected calving date in cows.
• Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Adverse reactions
• Transient inflammation, erythema, dandruff, broken/brittle hair, thinning hair, alopecia, or thickening of the skin has been detected at the administration site. Specific treatment is usually not required.
• Some animals may temporarily show signs of irritation, agitation or discomfort after application of the veterinary medicinal product.
• On very rare occasions, anaphylactic reactions may occur, which can be severe, and must be treated symptomatically.

Route of administration
Dorsal anointing continues.

Posology
Cattle: Single administration. The recommended treatment dose is 3,33 mg flunixin/kg bw (equivalent to 1 ml/15 kg bw).
• The bottle dosing chamber is calibrated in kilograms of live weight. To ensure administration of a correct dose, weight should be determined as accurately as possible.
• Practice administration following the instructions a few times to become familiar with how the package works before administration to animals.
Step 1: On first use, remove cap and peel-off seal from dispensing chamber. Do not remove the cap from the bottle.
Step 2: Hold the bottle upright and at eye level while slowly and gently squeezing the bottle to fill the dosing chamber to the selected mark.
Step 3: Pour the measured volume on the midline of the animal's back that extends from the withers to the beginning of the tail. Localized applications in smaller areas should be avoided.

Special precautions
• Apply only to dry skin and avoid getting the area wet for at least 6 hours after administration.
• In case of bacterial infections, a simultaneous antibiotic treatment should be considered.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to have the potential to delay labor through a tocolytic effect by inhibiting prostaglandins that are important in marking the onset of labor. Use of the veterinary medicinal product in the immediate postpartum period may interfere with uterine involution and expulsion of the fetal membranes, resulting in retained placenta.
• No safety studies have been carried out in bulls intended for breeding. Laboratory studies in rats have not shown any evidence of reproductive toxicity. Use only in accordance with a risk/benefit assessment by the responsible veterinarian.
• Use in pre-ruminant calves and older animals may carry additional risks.
If such uses cannot be avoided, animals may require reduced dosage and careful clinical monitoring.
• Apply only to intact skin.
• Personal protective equipment consisting of impervious gloves, protective clothing and approved safety glasses should be worn while using this veterinary medicinal product.
• Ingestion or dermal contact with the veterinary medicinal product may be harmful. Do not smoke, eat or drink while handling the veterinary medicinal product. Prevent children from having access to the veterinary medicinal product or treated animals. Wash hands after use. In case of accidental ingestion or contact with the mouth, immediately rinse the mouth with plenty of water and seek medical assistance.
• Non-steroidal anti-inflammatory drugs (NSAIDs) can cause hypersensitivity (allergy). People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product.
• The veterinary medicinal product has been shown to cause serious and irreversible eye damage. Avoid contact with eyes, including hand-eye contact. In case of eye contact, immediately rinse eyes with large amounts of clean water and seek medical assistance.
• The veterinary medicinal product has been shown to cause slight skin irritation. Avoid contact with skin. In case of skin contact, wash thoroughly with soap and water. Avoid contact with the treated area (including diffusion of the veterinary medicinal product) without protective gloves, for at least three days or until the application site is dry (if longer).
Use during pregnancy or lactation:
• It can be used during pregnancy and lactation except within 48 hours prior to delivery.
• Due to an increased risk of retained placenta, the veterinary medicinal product should only be administered within the first 36 hours after parturition following a benefit/risk assessment by the responsible veterinarian and treated animals should be monitored to avoid retention. of placenta.

have waiting time
Si
Wait time
Meat: 7 days.
Milk: 36 hours.
• Given the possibility of cross-contamination from animals not treated with this veterinary medicinal product due to grooming (licking), treated animals should be kept separate from untreated animals throughout the withdrawal period. Failure to follow this recommendation may result in residues in untreated animals.

conservation mode
This veterinary medicinal product does not require special storage conditions.
Shelf-life after first opening the immediate package: 6 months.

Comments
Veterinary use. Medicine subject to a veterinary prescription.
Veterinary prescription required
Si

Formats
CNN Reg. Formats
FINADYNE® TRANSDERMAL 50 mg/ml Pour-on Solution for Cattle
583307 3044 ENG Box with 1 bottle of 100 ml
583308 3044 ENG Box with 1 bottle of 250 ml
583309 3044 ENG Box with 1 bottle of 1000 ml

See technical sheet